— Know what they know.
Not Investment Advice

FNAM OTC

Evolutionary Genomics, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 46 · $1331 mcap · 4M float · 0.0062% daily turnover

Balance Sheet Trends

Total Assets
$2M -19.7% ▼
5Y CAGR: -15.3%
Total Liabilities
$4M -46.5% ▼
5Y CAGR: -0.4%
Shareholders Equity
-$2M -88.8% ▼
Cash & Investments
$577K +169.6% ▲
5Y CAGR: -13.2%
Total Debt
$4M +0.0% ▲
Net Debt
$3M -10.3% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2018FY2019FY2020FY2021FY2022
— Assets —
Cash$131K$45K$216K$214K$577K
Short-Term Investments$28K$42K$0$0$0
Cash & ST Investments$160K$87K$216K$214K$577K
Net Receivables$40K$7K$0$0$78K
Inventory$0-$42K$0$0$0
Other Current Assets$0$42K$0$0$0
Total Current Assets$223K$118K$278K$256K$699K
Property, Plant & Equip.$127K$89K$51K$19K$4K
Goodwill & Intangibles$4M$4M$4M$3M$2M
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$16K-$11K-$903K$0$0
Total Non-Current Assets$4M$4M$4M$3M$2M
Total Assets$4M$4M$4M$3M$2M
— Liabilities —
Accounts Payable$0$19K$3K$19K$178K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$0$19K$3K$19K$178K
Long-Term Debt$0$0$2M$4M$4M
Other Non-Current Liab.$3M$4M$4M$4M$0
Total Non-Current Liabilities$4M$5M$6M$7M$4M
Total Liabilities$4M$5M$6M$7M$4M
— Equity —
Common Stock$6K$6K$6K$6K$7K
Retained Earnings-$13M-$13M-$15M-$18M-$20M
Accumulated OCI-$377K$0$0$0$0
Total Stockholders Equity$404K-$334K-$2M-$4M-$2M
Total Liabilities & Equity$4M$4M$4M$3M$2M
— Key Metrics —
Total Debt$0$0$2M$4M$4M
Net Debt-$131K-$45K$2M$4M$3M
Total Investments$28K$42K$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms